Fox Run Management L.L.C. Sells 6,065 Shares of GE HealthCare Technologies Inc. $GEHC

Fox Run Management L.L.C. decreased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 35.0% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 11,270 shares of the company’s stock after selling 6,065 shares during the period. Fox Run Management L.L.C.’s holdings in GE HealthCare Technologies were worth $835,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. JPMorgan Chase & Co. grew its stake in shares of GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after acquiring an additional 1,711,963 shares in the last quarter. Nuveen LLC purchased a new position in GE HealthCare Technologies during the first quarter worth about $77,058,000. Eminence Capital LP boosted its holdings in GE HealthCare Technologies by 38.7% during the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after purchasing an additional 507,101 shares during the last quarter. Homestead Advisers Corp grew its position in GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after purchasing an additional 475,500 shares in the last quarter. Finally, Canada Pension Plan Investment Board increased its stake in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after buying an additional 409,636 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on GEHC shares. BTIG Research set a $87.00 target price on GE HealthCare Technologies in a research note on Wednesday, October 29th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Barclays started coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $93.00 to $83.00 in a research note on Tuesday, October 7th. Finally, Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average target price of $86.10.

GE HealthCare Technologies Stock Down 1.5%

Shares of NASDAQ GEHC opened at $73.05 on Monday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The stock has a market capitalization of $33.28 billion, a PE ratio of 15.09, a P/E/G ratio of 2.75 and a beta of 1.13. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The business’s fifty day moving average price is $75.12 and its 200-day moving average price is $73.56.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.